|
|
|
|
|
|
|
|
|
|
|
|
|
<TABLE> <S> <C>
<ARTICLE> 5
<CIK> 0000351532
<NAME> INTERFERON SCIENCES, INC.
<MULTIPLIER> 1
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> JUN-30-2000
<CASH> 3,391,236
<SECURITIES> 0
<RECEIVABLES> 128,097
<ALLOWANCES> 0
<INVENTORY> 735,203
<CURRENT-ASSETS> 4,283,118
<PP&E> 12,759,273
<DEPRECIATION> 10,076,311
<TOTAL-ASSETS> 7,180,968
<CURRENT-LIABILITIES> 3,403,972
<BONDS> 0
0
0
<COMMON> 124,824
<OTHER-SE> 3,652,172
<TOTAL-LIABILITY-AND-EQUITY> 7,180,968
<SALES> 321,072
<TOTAL-REVENUES> 321,072
<CGS> 655,330
<TOTAL-COSTS> 655,330
<OTHER-EXPENSES> 1,288,725
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 10,399
<INCOME-PRETAX> (1,633,382)
<INCOME-TAX> 0
<INCOME-CONTINUING> (1,633,382)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (1,633,382)
<EPS-BASIC> (.22)
<EPS-DILUTED> (.22)
</TABLE>
|
|